Dx Deals: Quest Closes PathAI Partial Acquisition and Strategic Alliance
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
From - Laboratory Industry Report
The past few weeks have brought snow to parts of the country that don't usually see the white stuff, and a flurry of…
From - Laboratory Industry Report
Greek philosopher Heraclitus said the only thing constant is change. Although he never managed a diagnostic laboratory, his words…
From - Laboratory Industry Report
After a slow January, new product development picked up steam in February. Here's a rundown of the key new launches…
From - Laboratory Industry Report
The diagnostics industry capped a robust 2018 with most companies posting strong fourth quarter results. Of course…
From - Laboratory Industry Report
On Jan. 22, the FDA issued final guidance establishing a new alternative pathway for getting medical devices to…
By Dan Scungio, MT (ASCP), SLS, CQA (ASQ) bio
I read a written Laboratory Emergency Management Plan, and at the end of the document there was a short section called…
From - Laboratory Industry Report
Late December through January was fairly slow for new product launches in terms of both volume and impactful-ness. Here's a rundown of…
From - Laboratory Industry Report
Continuing a four-year trend, total U.S. venture capital investment in health care surged in 2018, reaching a new all-time high of…